Science & Enterprise subscription

Follow us on Twitter

  • An industry-academic consortium received a U.S. government contract to develop coded synthetic polymer chemicals li… https://t.co/AqWMpFYG5Q
    about 15 hours ago
  • New post on Science and Enterprise: Synthetic DNA Studied for Mass Data Storage https://t.co/XeKsILkGR0 #Science #Business
    about 15 hours ago
  • Engineers developed a more sustainable type of concrete adding a form of bacteria to grow and reproduce the materia… https://t.co/7naaOf9CYF
    about 19 hours ago
  • New post on Science and Enterprise: Living, Reproducing Concrete Created with Bacteria https://t.co/1RWPEfpvmz #Science #Business
    about 19 hours ago
  • Smart money? The US company receiving the most venture capital money through 2019 is e-cigarette maker Juul Labs, a… https://t.co/YHMyj4Aavo
    about 2 days ago

Please share Science & Enterprise

Pharma Gains Fibrosis Technology in $1B+ Deal

Stuart Cook

Drug maker Boehringer Ingelheim is acquiring an antibody technology that blocks actions of a signaling protein associated with a range of fibrosis diseases. . . . → Read More: Pharma Gains Fibrosis Technology in $1B+ Deal

Vaccine Developer Gains $11M in Early Funds

Baby with microcephaly

A company designing vaccines delivered with a microneedle patch to prevent infectious diseases is raising $11 million in its first venture funding round. . . . → Read More: Vaccine Developer Gains $11M in Early Funds

Laser Images, A.I. Diagnose Brain Tumors

Brain tumor graphic

Results of a clinical trial show laser images analyzed by machine learning algorithms can offer near real-time diagnosis of brain tumor tissue during surgery. . . . → Read More: Laser Images, A.I. Diagnose Brain Tumors

Biotech Options Enzyme Inhibitors for Lung Cancer

Human lungs illustration

A biotechnology company developing inhaled drugs for respiratory diseases agreed to provide Johnson & Johnson with access to its technology for treating lung cancer. . . . → Read More: Biotech Options Enzyme Inhibitors for Lung Cancer

Artificial Pancreas System Cleared by FDA

Artificial pancreas system

A system for automatically measuring blood glucose levels and dispensing insulin for people with type 1 diabetes is authorized by the Food and Drug Administration. . . . → Read More: Artificial Pancreas System Cleared by FDA

Tomato Genetics Altered for Urban Farms

Gene-altered tomatoes

Plant scientists used a genome-editing technique to produce varieties of tomatoes better suited for growing on urban farms and other small plots. . . . → Read More: Tomato Genetics Altered for Urban Farms

Engineered Viruses Licensed for Cancer Therapies

Vaccinia virus

A biotechnology company developing cancer immunotherapies with synthetic viruses is licensing its technology to Takeda Pharmaceuticals. . . . → Read More: Engineered Viruses Licensed for Cancer Therapies

Duke Univ Forms Drug Development Company

Lab jars and beakers

Duke University and life science investor Deerfield Management are forming a new enterprise to develop drug candidates through early development stages. . . . → Read More: Duke Univ Forms Drug Development Company

Nature, Merck Establish Science Entrepreneur Prize

Test tubes in a lab

The scientific publisher Springer Nature and drug maker Merck are creating an annual award for early-stage companies spun-off from academic research. . . . → Read More: Nature, Merck Establish Science Entrepreneur Prize

Engineered Virus Aids Gene Therapy Delivery

Adeno-associated virus

A university bio-engineering lab and start-up company are developing synthetic variations of viruses to more reliably deliver gene therapies. . . . → Read More: Engineered Virus Aids Gene Therapy Delivery